Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Devon Park BioVentures

Venture Capital Philadelphia, Pennsylvania, United States ·Founded 2006

Overview

Devon Park BioVentures is a venture capital firm specializing in investments in life sciences companies. The firm focuses on sectors such as therapeutics, medical devices, diagnostics, and drug discovery technologies. Their investment strategy targets companies with significant commercial potential, emphasizing proprietary products, attractive clinical development plans, and strong management teams. Devon Park BioVentures seeks to invest in companies with tangible assets that are undervalued due to perceived risks or underestimated market potential. The firm's investment approach includes both early and later-stage funding, aiming to support companies through various phases of development. Their portfolio spans across the United States, reflecting a broad geographical focus within the life sciences sector. Devon Park BioVentures is committed to fostering innovation and growth in the healthcare and biotechnology industries. With a history of strategic investments, the firm has contributed to the advancement of several companies in the medical device, diagnostic, and pharmaceutical sectors. Their expertise and resources are dedicated to nurturing companies that have the potential to make significant impacts in the healthcare industry.

Investment Focus

Proprietary products
Attractive clinical development plans
Superior management teams

Reach Devon Park BioVentures directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Devon Park BioVentures

What sectors does Devon Park BioVentures invest in?

Devon Park BioVentures invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Philadelphia, Pennsylvania, United States. Devon Park BioVentures is listed as a venture capital in the ConnectSafely investor database.